Redensity 2 Filler in London
Teosyal Redensity 2 represents a breakthrough in addressing delicate under-eye concerns through advanced dermal filler technology. Developed by Teoxane Laboratories, this hyaluronic acid-based filler specifically designed to treat tear trough area combines cross-linked and non-cross-linked hyaluronic acid with essential nutrients. The injection procedure typically requires 20-30 minutes, delivering immediate luminosity while progressively improving dark circles and hollow contours over subsequent weeks.
Thousands of satisfied customers
Redensity 2 Pricing Overview in London
Treatment Area | Price Range | Syringes | Duration |
Under Eyes | £350 – £450 | 0.5-1 | 9-12 months |
Tear Troughs | £350 – £500 | 1 | 9-12 months |
Eye Area Enhancement | £400 – £550 | 1-1.5 | 9-12 months |
Full Periorbital | £500 – £650 | 1.5-2 | 12-15 months |
Returning patients benefit from 10% reduction on subsequent appointments. Combined treatment plans pairing Teosyal Redensity with complementary aesthetics procedures receive package pricing, reducing overall investment by 15-20%. Seasonal promotions occasionally extend additional value for multi-area filler treatments.
Before and After
Observable transformations emerge immediately following injection, with initial radiance enhancement visible as skin hydration increases. Full refinement manifests within 3-5 days once subtle swelling subsides, revealing softer contours around the eyes and diminished appearance of circles under the eyes. Patients consistently report rejuvenated appearance without artificial volume, maintaining natural facial expressions. The advanced dermal filler integrates seamlessly with surrounding tissue, promoting skin vitality through sustained delivery of amino acids and antioxidant components. Results typically reach optimal expression two weeks post-procedure, when collagen stimulation begins contributing to long-term improvement.
What is Redensity 2?
Manufacturer and Origin
Teoxane Laboratories, a Swiss innovator in medical aesthetics, developed Teosyal Puresense Redensity 2 through extensive research into periorbital rejuvenation challenges. This injectable distinguishes itself as the first hyaluronic acid filler containing patent-protected formulation of eight amino acids—glycine, lysine, threonine, proline, isoleucine, leucine, valine, and arginine—alongside three antioxidant compounds and vitamin B6. The mixture of cross-linked and non-cross-linked hyaluronic acid specifically indicated for under-eye treatment provides dual functionality: immediate volumization through cross-linked molecules and sustained hydration via non-cross-linked components.
Certifications and Regulatory Approval
Manufacturing standards meet both FDA recognition and CE certification requirements, ensuring consistent quality across production batches. The gel viscosity remains deliberately lower than traditional dermal filler products, accommodating the delicate nature of periorbital tissue where excessive firmness creates visible irregularities. Particle size engineering allows smooth integration within thin dermis layers characteristic of the trough area, minimising risk of Tyndall effect—the bluish discoloration sometimes observed with inappropriate filler selection.
Composition and Formulation
Teosyal Redensity 2 contains specifically calibrated hyaluronic acid concentration (15mg/ml) balanced with essential nutrients to refresh cellular microenvironment. Unlike conventional fillers prioritizing volume restoration alone, this formulation addresses multiple aging mechanisms simultaneously: structural support, moisture retention, and metabolic nourishment. Practitioner preference stems from its predictable behavior during injection procedure, reduced tendency toward bruise formation, and compatibility with cannula delivery methods.
Comparative Analysis
Comparing alternatives reveals distinct positioning: while standard eye filler products like Restylane Eyelight emphasize pure volumization, Redensity II prioritizes comprehensive tissue quality improvement. Belotero Balance offers similar delicate consistency but lacks the nutritional complex. Juvéderm Volbella provides longer duration through different cross-linking technology, yet practitioner feedback suggests Teosyal range delivers superior natural feel in tear trough applications. Cost-benefit analysis across London skin clinic networks consistently positions Teosyal Puresense Redensity 2 as optimal choice for patients seeking refined under-eye enhancement without overcorrection risks.
The Redensity 2 Treatment Process: Step by Step
Consultation Phase
Initial assessment examines bone structure, fat pad positioning, and skin thickness around the eyes. Practitioners analyze how light interacts with existing hollows, determining injection depth and volume requirements. Discussion establishes realistic expectations, reviews medical history, and photographs document baseline appearance. This personalized treatment planning typically requires 15-20 minutes.
Preparation Protocol
Facial cleansing removes makeup and surface oils. Strategic marking identifies injection sites along the orbital rim where filler designed placement maximizes natural contour restoration. Numbing cream application (if requested) requires 15 minutes activation time, though many patients proceed without topical anesthesia given Redensity 2’s integrated lidocaine content and the practitioner’s skilled technique.
Injection Technique
Using either fine needle or blunt-tipped cannula, the aesthetic practitioner introduces small aliquots of Teoxane product along predetermined vectors. For tear trough correction, superficial placement within dermal layers prevents visible lumps while supporting skin from beneath. Gentle massage distributes material evenly, preventing concentration in single areas. The specifically designed formulation flows smoothly during inject phases, allowing precise control.
Contouring Refinement
Real-time assessment from multiple angles ensures symmetrical enhancement. Minor adjustments address any asymmetry, with additional micro-droplets placed as needed. This artistic phase distinguishes experienced injectors, requiring thorough understanding of facial anatomy and three-dimensional visualization skills.
Completion Protocol
Cold compress application reduces immediate redness and potential swelling. Detailed aftercare instructions cover sleeping position (elevated), activity restrictions (48-hour exercise avoidance), and signs warranting follow-up contact. Patients leave with emergency contact information and scheduled review appointment.
Time Investment
Complete procedure spans 30-45 minutes, including preparation and post-treatment photography. Recovery remains minimal, with most individuals resuming normal activities immediately, though visible pin-prick marks may persist 24 hours.
Benefits of Redensity 2 Filler
Natural aesthetic outcomes emerge as the primary advantage—Teosyal Redensity refreshes appearance without creating artificial fullness. The hyaluronic acid and essential nutrients combination addresses both structural and biochemical aspects of periorbital aging, distinguishing it from single-mechanism treatments.
Duration extends 9-12 months for most recipients, with some patients reporting sustained improvement approaching 15 months. This longevity reflects the dual-action formula where non-cross-linked hyaluronic acid specifically indicated components metabolize gradually while stimulating endogenous processes.
Downtime remains exceptionally brief. Unlike surgical alternatives requiring weeks of recovery, filler treatments using Redensity allow immediate return to professional and social commitments. Minor swelling typically resolves within 48-72 hours, easily concealed with makeup if desired.
Versatility permits application across multiple periorbital concerns: tear troughs and dark circles, subtle volume loss, crepey texture, and luminosity reduction. The same product addresses these varied presentations through adjusted injection depth and volume.
Safety profile benefits from extensive clinical testing and post-market surveillance data. The hyaluronic acid-based filler composition ensures complete biodegradability, eliminating permanent implant risks. Should adjustment prove necessary, hyaluronidase enzyme reversal remains available—a critical safety feature distinguishing hyaluronic formulations from permanent alternatives.
Migration resistance stems from optimal viscosity calibration. Unlike lighter gels potentially shifting from placement sites, Teosyal Puresense Redensity 2 maintains position while integrating naturally. Practitioners observe stable results without inferior displacement commonly associated with overly fluid formulations.
Combination compatibility allows strategic pairing with complementary aesthetics interventions. Patients frequently combine tear trough filler with BT for crow’s feet, skin boosters for texture improvement, or laser treatments addressing pigmentation. The amino acids content supports healing processes, potentially enhancing results from concurrent procedures.
Our Redensity 2 Treatment Options in London
Standard Enhancement (1ml)
Single syringe addresses mild to moderate hollowing, typically distributed between both eyes. This foundational approach suits first-time patients or those requiring subtle refresh after previous treatment. Expected investment: £350-£450.
Comprehensive Correction (1.5-2ml)
More pronounced volume deficits or broader periorbital concerns benefit from extended product allocation. Additional material permits addressing not only tear trough area but also lateral cheek blending for seamless transition. Investment range: £500-£650.
Combination Protocols
Pairing Teosyal Redensity II with complementary modalities optimizes outcomes. Popular configurations include:
- Redensity 2 + Skin Booster (improving texture alongside structure): £550
- Eye Filler + BT (addressing both static and dynamic concerns): £600
- Full Face Rejuvenation (multiple areas with coordinated planning): Custom pricing
Progressive Programs
Patients with significant volume loss may benefit from staged approach, building results across 2-3 sessions spaced 4-6 weeks apart. This measured strategy prevents overcorrection while allowing adjustment based on initial response. Program pricing offers 15% reduction versus individual session costs.
Maintenance Sessions
Following initial correction, refresh injections every 9-12 months preserve results with reduced product requirements. Many patients find 0.5ml suffices for maintenance, representing significant cost efficiency. Loyalty pricing applies to returning patients maintaining regular schedule.
Customization remains paramount consultation assessment determines appropriate protocol based on individual anatomy, aging patterns, aesthetic goals, and budget considerations. No standardized approach applies universally; instead, experienced practitioners craft bespoke strategies honoring each patient’s unique presentation.
Why Choose Our London Clinic for Redensity 2?
Practitioner Expertise and Credentials
Our medical team holds advanced credentials in aesthetic medicine, with practitioners maintaining active registration with relevant regulatory bodies. Continuous education ensures familiarity with evolving injection techniques and emerging safety protocols. Specialization in facial anatomy, particularly complex periorbital region, distinguishes our approach from general cosmetic providers.
Authentic Product Guarantee
Product authenticity verification accompanies every treatment. Direct sourcing relationships with Teoxane laboratories guarantee genuine Teosyal range products, eliminating counterfeit risks plaguing less scrupulous providers. Patients receive batch number documentation and can independently verify authenticity through manufacturer databases.
Results Assurance
Results guarantee policy demonstrates our confidence: should outcomes fail meeting pre-discussed expectations, complimentary adjustment occurs within designated timeframe. This commitment extends beyond mere customer service—it reflects our understanding that individual responses vary and our willingness to achieve satisfaction.
Complication Insurance Coverage
Comprehensive insurance coverage protects both patients and practitioners. Clinical indemnity policies specific to injectable treatments ensure financial protection should unexpected complications arise. While serious adverse events remain extraordinarily rare with hyaluronic acid filler, this coverage provides peace of mind.
Personalized Treatment Planning
Personalized treatment planning begins with thorough assessment, extending through follow-up monitoring. We avoid one-size-fits-all protocols, instead investing time understanding each patient’s concerns, lifestyle factors, and aesthetic philosophy. Digital imaging technology aids visualization of potential outcomes, facilitating informed decision-making.
Post-Treatment Monitoring
Aftercare accessibility remains priority—patients receive direct contact information and know they can reach qualified medical staff with concerns. Scheduled follow-up (complimentary two-week review) ensures satisfactory integration and addresses any questions emerging post-procedure. This ongoing relationship model contrasts with transactional approach of some providers.
Redensity 2 vs Other Fillers: Comparison Chart
Feature | Redensity 2 | Restylane Eyelight | Belotero Balance |
Duration | 9-12 months | 6-9 months | 6-9 months |
Price | £350-450 | £300-400 | £280-380 |
Viscosity | Low (optimized) | Low-Medium | Very Low |
Best For | Tear troughs, dark circles | Under-eye hollows | Fine lines, superficial |
Recovery Time | 1-2 days | 2-3 days | 1-2 days |
Natural Feel | Excellent | Good | Excellent |
Amino Acid Complex | Yes (8 types) | No | No |
Antioxidant Content | Yes | No | No |
Cannula Compatible | Yes | Yes | Limited |
Tyndall Risk | Minimal | Low | Minimal |
Frequently Asked Questions About Redensity 2
How long does Redensity 2 last?
Clinical studies and real-world experience demonstrate 9-12 month duration for most patients receiving tear trough filler treatment. Individual metabolism, lifestyle factors (sun exposure, smoking), and anatomical characteristics influence longevity. Some recipients report sustained improvement approaching 15 months, while others notice gradual resolution beginning around 8 months. The non-cross-linked hyaluronic acid component metabolizes more rapidly than cross-linked fraction, creating staged resorption rather than abrupt disappearance.
Is Redensity 2 safe?
Teosyal Puresense Redensity 2 maintains extensive safety documentation through clinical trials, post-market surveillance, and regulatory approvals including CE marking. The hyaluronic acid-based filler composition utilizes substance naturally present in human tissue, minimizing allergic reaction risk. Manufacturing occurs under pharmaceutical-grade conditions with rigorous quality control. Common side effects remain limited to injection-related responses: temporary redness, minor swelling, occasional bruise formation—all typically resolving within 48-96 hours.
Can I combine Redensity 2 with other treatments?
Combination strategies frequently enhance overall outcomes. BT addressing dynamic wrinkles around the eyes complements the volumizing effect of eye filler, creating comprehensive rejuvenation. Skin boosters improving dermal quality pair logically with Teosyal Redensity’s structural support. Laser treatments targeting pigmentation can safely proceed 2-3 weeks before or after the injection procedure. Chemical peels, microneedling, and radiofrequency treatments require appropriate spacing (typically 2-4 weeks) to avoid interference.
What are the side effects?
Expected responses include mild tenderness at injection sites, transient swelling (especially noticeable morning after treatment), and potential bruising. These reactions reflect normal tissue response to needle insertion rather than filler-specific issues. Swelling typically peaks 24-48 hours post-procedure, then gradually subsides over 3-5 days. Cold compress application and sleeping with elevated head position minimize this effect.
When will I see results?
Initial improvement appears immediately as the hyaluronic acid filler provides instant volume, though this includes slight swelling component. True result appreciation occurs 3-5 days post-treatment once inflammatory response completely subsides. Subtle continued enhancement develops over subsequent 2-3 weeks as skin hydration increases and collagen stimulation begins. Patients should evaluate final outcome at two-week mark when scheduling review appointments. Photographs taken during consultation allow objective comparison. Some individuals report progressive improvement extending 4-6 weeks as the essential nutrients exert metabolic effects on surrounding tissue quality. This delayed optimization distinguishes Redensity II from pure volumizers delivering only immediate structural change.
Can Redensity 2 be reversed?
Hyaluronidase enzyme effectively dissolves hyaluronic acid-based products including Teosyal range formulations. Should results prove unsatisfactory or complications arise, practitioners can inject hyaluronidase to accelerate filler breakdown. The enzyme works rapidly—often producing visible reduction within hours—though full reversal may require 24-48 hours. Multiple treatments occasionally prove necessary for complete removal, depending on product volume and integration degree. This reversibility represents crucial safety advantage over permanent or semi-permanent injectable options.
How much Redensity 2 do I need?
Volume requirements vary substantially based on anatomical presentation. Mild hollowing might require only 0.5ml total (0.25ml per side), while more pronounced volume deficits could utilize 1.5-2ml for optimal correction. Practitioners assess several factors: bone structure, fat pad positioning, skin thickness, and desired outcome subtlety. Conservative initial treatment with planned follow-up adjustment often proves preferable to overcorrection.
Is there downtime?
Functional recovery occurs immediately—patients can resume most activities directly following treatment. Social downtime remains minimal, typically limited to 24-48 hours during which minor swelling or injection marks may be visible. Most individuals return to work the same day, using concealer if desired to mask pin-prick sites. Strenuous exercise warrants 48-hour avoidance to prevent exacerbating swelling through increased blood flow. Alcohol consumption should pause 24 hours as it promotes bruising and inflammation.
Who is the ideal candidate for this treatment?
Suitable candidates present with tear troughs and dark circles stemming from structural volume loss rather than purely pigmentary concerns. Individuals with realistic expectations understanding that filler designed interventions provide improvement rather than perfection achieve highest satisfaction. Good general health, non-smoking status, and absence of active periorbital infections or inflammatory conditions support optimal outcomes. Patients committed to maintaining results through periodic refresh treatments maximize their investment. Those with very thin skin require careful evaluation, as filler visibility risk increases; however, the specifically designed low-viscosity formula of Redensity 2 minimizes this concern.
How should I prepare for my appointment?
Avoiding blood-thinning substances 5-7 days pre-treatment minimizes bruise risk: aspirin (unless medically necessary), ibuprofen, fish oil, vitamin E, and certain herbal supplements. Arnica tablets begun 2-3 days prior may reduce bruising tendency. Arrive with clean face, removing makeup beforehand or allowing extra time for clinic cleansing. Hydration supports optimal tissue condition—increasing water intake the week before treatment proves beneficial. Schedule appointments when stress levels permit proper recovery rest.